Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
Clinical trial NCT00953771 · TERMINATED
Trial details
- NCT number
- NCT00953771
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2015-11-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.